This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Yuhong Fang: Innovator in Peptide Deformylase Inhibitors
Introduction
Yuhong Fang is a notable inventor based in Eagleville, Pennsylvania. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of peptide deformylase inhibitors. His work is crucial in addressing bacterial infections and enhancing treatment methods.
Latest Patents
Yuhong Fang holds one patent related to peptide deformylase inhibitors. This patent describes a compound of Formula (I) or a pharmaceutically acceptable salt thereof, along with corresponding pharmaceutical compositions, compound preparation, and treatment methods aimed at inhibiting bacterial peptide deformylase (PDF) activity.
Career Highlights
Fang is associated with GlaxoSmithKline Intellectual Property (No. 2) Limited, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in the field has positioned him as a valuable asset in the development of new therapeutic agents.
Collaborations
Some of his notable coworkers include Kelly M. Aubart and Andrew B. Benowitz. Their collaborative efforts contribute to the advancement of research and development in their respective fields.
Conclusion
Yuhong Fang's work in peptide deformylase inhibitors exemplifies the importance of innovation in combating bacterial infections. His contributions to the pharmaceutical industry are significant and continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile